Director Kingsley Stuart buys 940 INDV shares at $31.86; holdings rise to 5,582 shares (+20.2%)
Kingsley Stuart, a director of Indivior Pharmaceuticals, purchased 940 shares at $31.86 on 2026-03-06, increasing his position from 4,642 to 5,582 shares—a 20.2% increase in holdings. The purchase occurred at a price $0.97 below the current market price of $32.83, and within the 52-week range ($8.81–$36.60), slightly below the recent 52-week high. The company is profitable with $42.0M in net income on $314.0M quarterly revenue and a reasonable P/E of 12.39, suggesting stable fundamentals. The timing comes amid 30-day and 90-day declines of -3.0% and -8.3% respectively, placing the purchase in a period of near-term weakness relative to recent highs.